Summary

This article highlights some important features of HER2-positive breast cancer. These include a review of some of the molecular mechanisms implicated in tumorigenesis, how certain therapies are used to interfere with these processes, the benefits of neoadjuvant therapy, and the treatment of patients with metastatic disease.